APP and Alzheimer disease: The recent progress in the investigation of structural properties of APP and its derivatives, their aggregated forms, and their complexes with relevant biological and pharmaceutical molecules has notably advanced our understanding of the molecular bases of pathogenic processes associated with AD and has drawn a clearer demarcation line between them and the normal functions of APP processing products.